Search Results

There are 6543 results for: content related to: Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

  1. You have free access to this content
    Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population

    BJU International

    Volume 116, Issue 3, September 2015, Pages: 382–387, Jeremy Y.C. Teoh, Samson Y.S. Chan, Peter K.F. Chiu, Darren M.C. Poon, Ho-Yuen Cheung, Simon S.M. Hou and Chi-Fai Ng

    Version of Record online : 7 MAR 2015, DOI: 10.1111/bju.12967

  2. Risk of new-onset diabetes after androgen deprivation therapy for prostate cancer in the Asian population

    Journal of Diabetes

    Volume 7, Issue 5, September 2015, Pages: 672–680, Jeremy Yuen Chun Teoh, Peter Ka Fung Chiu, Samson Yun Sang Chan, Darren Ming Chun Poon, Ho-Yuen Cheung, Simon See Ming Hou and Chi-Fai Ng

    Version of Record online : 22 DEC 2014, DOI: 10.1111/1753-0407.12226

  3. You have free access to this content
    A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 924–928, Howard S. Kim, Daniel M. Moreira, Matthew R. Smith, Joseph C. Presti Jr, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling and Stephen J. Freedland

    Version of Record online : 22 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09679.x

  4. You have free access to this content
    Adverse effects of androgen-deprivation therapy in prostate cancer and their management

    BJU International

    Volume 115, Issue S5, April 2015, Pages: 3–13, Handoo Rhee, Jennifer H. Gunter, Peter Heathcote, Ken Ho, Phillip Stricker, Niall M. Corcoran and Colleen C. Nelson

    Version of Record online : 1 APR 2015, DOI: 10.1111/bju.12964

  5. You have free access to this content
    Androgen deprivation therapy: evidence-based management of side effects

    BJU International

    Volume 111, Issue 4, April 2013, Pages: 543–548, Hamed Ahmadi and Siamak Daneshmand

    Version of Record online : 25 JAN 2013, DOI: 10.1111/j.1464-410X.2012.11774.x

  6. Altered association of interleukin-6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy

    The Prostate

    Volume 72, Issue 11, 1 August 2012, Pages: 1207–1213, Shuichi Komatsu, Noboru Hara, Fumio Ishizaki, Tsutomu Nishiyama, Itsuhiro Takizawa, Etsuko Isahaya, Takashi Kawasaki and Kota Takahashi

    Version of Record online : 27 DEC 2011, DOI: 10.1002/pros.22471

  7. You have free access to this content
    Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer

    BJU International

    Volume 116, Issue 3, September 2015, Pages: 358–365, David R. Ziehr, Ming-Hui Chen, Danjie Zhang, Michelle H. Braccioforte, Brian J. Moran, Brandon A. Mahal, Andrew S. Hyatt, Shehzad S. Basaria, Clair J. Beard, Joshua A. Beckman, Toni K. Choueiri, Anthony V. D'Amico, Karen E. Hoffman, Jim C. Hu, Neil E. Martin, Christopher J. Sweeney, Quoc-Dien Trinh and Paul L. Nguyen

    Version of Record online : 29 OCT 2014, DOI: 10.1111/bju.12905

  8. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

    The Prostate

    Volume 75, Issue 9, June 15, 2015, Pages: 897–906, Rebecca E. Graff, Andreas Pettersson, Rosina T. Lis, Natalie DuPre, Kristina M. Jordahl, Elizabeth Nuttall, Jennifer R. Rider, Michelangelo Fiorentino, Howard D. Sesso, Stacey A. Kenfield, Massimo Loda, Edward L. Giovannucci, Bernard Rosner, Paul L. Nguyen, Christopher J. Sweeney, Lorelei A. Mucci and on behalf of the Transdisciplinary Prostate Cancer Partnership ToPCaP

    Version of Record online : 1 MAR 2015, DOI: 10.1002/pros.22973

  9. You have free access to this content
    The impact of androgen-deprivation therapy (ADT) on the risk of cardiovascular (CV) events in patients with non-metastatic prostate cancer: a population-based study

    BJU International

    Volume 114, Issue 6b, December 2014, Pages: E82–E89, Giorgio Gandaglia, Maxine Sun, Ioana Popa, Jonas Schiffmann, Firas Abdollah, Quoc-Dien Trinh, Fred Saad, Markus Graefen, Alberto Briganti, Francesco Montorsi and Pierre I. Karakiewicz

    Version of Record online : 27 JUL 2014, DOI: 10.1111/bju.12732

  10. You have free access to this content
    Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?

    BJU International

    Volume 108, Issue 10, November 2011, Pages: 1588–1596, Murray Krahn, Karen E. Bremner, George Tomlinson, Jin Luo, Paul Ritvo, Gary Naglie and Shabbir M.H. Alibhai

    Version of Record online : 31 MAR 2011, DOI: 10.1111/j.1464-410X.2011.10127.x

  11. You have free access to this content
    Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy influences the response

    BJU International

    Volume 99, Issue 5, May 2007, Pages: 1024–1027, Tyler Y. Kang, Peter Nichols, Eila Skinner, Susan Groshen, Greg Valin, Wei Ye and Derek Raghavan

    Version of Record online : 22 JAN 2007, DOI: 10.1111/j.1464-410X.2006.06738.x

  12. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life

    The Journal of Sexual Medicine

    Volume 7, Issue 9, September 2010, Pages: 2996–3010, Stacy Elliott, David M. Latini, Lauren M. Walker, Richard Wassersug, John W. Robinson and the ADT Survivorship Working Group

    Version of Record online : 7 JUL 2010, DOI: 10.1111/j.1743-6109.2010.01902.x

  13. You have free access to this content
    Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 13–21, C. Schulman, J. Irani and M. Aapro

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11216.x

  14. You have free access to this content
    Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2603–2611, Rana R. McKay, Kathryn P. Gray, Julia H. Hayes, Glenn J. Bubley, Jonathan E. Rosenberg, Arif Hussain, Philip W. Kantoff and Mary-Ellen Taplin

    Version of Record online : 22 APR 2015, DOI: 10.1002/cncr.29398

  15. You have free access to this content
    Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer

    Cancer

    Volume 112, Issue 6, 15 March 2008, Pages: 1247–1253, Robert W. Ross, Wanling Xie, Meredith M. Regan, Mark Pomerantz, Mari Nakabayashi, Timothy J. Daskivich, Oliver Sartor, Mary-Ellen Taplin, Philip W. Kantoff and William K. Oh

    Version of Record online : 18 JAN 2008, DOI: 10.1002/cncr.23304

  16. You have free access to this content
    Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners

    Cancer

    Volume 121, Issue 24, December 15, 2015, Pages: 4286–4299, Kristine A. Donovan, Lauren M. Walker, Richard J. Wassersug, Lora M. A. Thompson and John W. Robinson

    Version of Record online : 15 SEP 2015, DOI: 10.1002/cncr.29672

  17. You have free access to this content
    Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

    Cancer

    Volume 115, Issue 5, 1 March 2009, Pages: 981–987, Toni K. Choueiri, Wanling Xie, Anthony V. D'Amico, Robert W. Ross, Jim C. Hu, Mark Pomerantz, Meredith M. Regan, Mary-Ellen Taplin, Philip W. Kantoff, Oliver Sartor and William K. Oh

    Version of Record online : 17 JAN 2009, DOI: 10.1002/cncr.24064

  18. You have free access to this content
    Androgen deprivation and thromboembolic events in men with prostate cancer

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3397–3406, Behfar Ehdaie, Coral L. Atoria, Amit Gupta, Andrew Feifer, William T. Lowrance, Michael J. Morris, Peter T. Scardino, James A. Eastham and Elena B. Elkin

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26623

  19. You have free access to this content
    The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms

    Cancer

    Volume 119, Issue 5, 1 March 2013, Pages: 1080–1088, Radka Stoyanova, Niraj H. Pahlajani, Brian L. Egleston, Mark K. Buyyounouski, David Y. T. Chen, Eric M. Horwitz and Alan Pollack

    Version of Record online : 23 OCT 2012, DOI: 10.1002/cncr.27857

  20. You have free access to this content
    Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue

    BJU International

    Volume 113, Issue 5, May 2014, Pages: 822–829, Fernando Korkes, Marilia Germanos de Castro, Stenio de Cassio Zequi, Lívia Nardi, Auro Del Giglio and Antonio Carlos de Lima Pompeo

    Version of Record online : 31 OCT 2013, DOI: 10.1111/bju.12339